Sergio H Marshall Selected Research

Bacterial Infections (Bacterial Infection)

1/2018	Extended antibiotic treatment in salmon farms select multiresistant gut bacteria with a high prevalence of antibiotic resistance genes.
5/2011	A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sergio H Marshall Research Topics

Disease

11	Infections 07/2021 - 11/2002
3	Piscirickettsiaceae Infections 12/2023 - 05/2011
3	Virus Diseases (Viral Diseases) 01/2021 - 01/2012
2	Bacterial Infections (Bacterial Infection) 01/2018 - 05/2011

Drug/Important Bio-Agent (IBA)

3	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 05/2011
3	Peptides (Polypeptides)IBA 07/2020 - 05/2011
2	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2016
1	Quillaja SaponinsIBA 07/2021
1	SaponinsIBA 07/2021
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 12/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2016
1	hemagglutinin esteraseIBA 04/2016
1	Antiviral Agents (Antivirals)IBA 04/2016
1	Interleukin-12 (IL 12)IBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	ClathrinIBA 01/2015
1	Type IV Secretion SystemsIBA 01/2015
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2013
1	RNA (Ribonucleic Acid)IBA 01/2012
1	flumequineIBA 05/2011
1	florfenicolIBA 05/2011
1	Oxolinic AcidIBA 05/2011
1	Peptide Elongation Factors (Elongation Factor)IBA 04/2010
1	TubulinIBA 04/2010
1	UbiquitinIBA 04/2010
1	Oxidoreductases (Dehydrogenase)IBA 04/2010
1	Actins (F Actin)IBA 04/2010
1	VaccinesIBA 11/2002
1	Neutralizing AntibodiesIBA 11/2002

Therapy/Procedure

1	Therapeutics 01/2012